Chevy Chase Trust Holdings, Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Chevy Chase Trust Holdings, Inc.

  • $35.7 Billion
  • Q3 2025

A detailed history of Chevy Chase Trust Holdings, Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Chevy Chase Trust Holdings, Inc. holds 203,152 shares of REGN stock, worth $141 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
203,152
Previous 206,728 1.73%
Holding current value
$141 Million
Previous $109 Million 5.25%
% of portfolio
0.32%
Previous 0.32%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025
SELL
$534.91 - $598.71 $1.91 Million - $2.14 Million
-3,576 Reduced 1.73%
203,152 $114 Million
Q2 2025

Jul 29, 2025
SELL
$483.07 - $625.6 $7 Million - $9.06 Million
-14,482 Reduced 6.55%
206,728 $109 Million
Q1 2025

Apr 23, 2025
SELL
$634.14 - $744.83 $5.43 Million - $6.37 Million
-8,557 Reduced 3.72%
221,210 $140 Million
Q4 2024

Jan 30, 2025
SELL
$701.85 - $1046.91 $6.04 Million - $9.02 Million
-8,612 Reduced 3.61%
229,767 $164 Million
Q3 2024

Nov 14, 2024
SELL
$1024.09 - $1201.76 $3.46 Million - $4.06 Million
-3,375 Reduced 1.4%
238,379 $251 Million
Q2 2024

Jul 22, 2024
SELL
$883.2 - $1071.19 $552,883 - $670,564
-626 Reduced 0.26%
241,754 $254 Million
Q1 2024

May 03, 2024
SELL
$902.69 - $993.35 $6.5 Million - $7.15 Million
-7,197 Reduced 2.88%
242,380 $233 Million
Q4 2023

Jan 24, 2024
SELL
$775.18 - $881.7 $1.04 Million - $1.19 Million
-1,344 Reduced 0.54%
249,577 $219 Million
Q3 2023

Oct 23, 2023
SELL
$692.45 - $844.37 $1.25 Million - $1.53 Million
-1,811 Reduced 0.72%
250,921 $206 Million
Q2 2023

Jul 25, 2023
SELL
$700.03 - $830.35 $1.22 Million - $1.44 Million
-1,736 Reduced 0.68%
252,732 $182 Million
Q1 2023

May 17, 2023
BUY
$680.49 - $826.97 $172 Million - $209 Million
252,546 Added 13139.75%
254,468 $209 Million
Q1 2023

May 15, 2023
SELL
$680.49 - $826.97 $174 Million - $212 Million
-256,212 Reduced 99.26%
1,922 $1.58 Billion
Q4 2022

Feb 09, 2023
SELL
$705.89 - $766.39 $15.7 Million - $17 Million
-22,210 Reduced 7.92%
258,134 $186 Million
Q3 2022

Nov 04, 2022
BUY
$573.97 - $724.32 $8.54 Million - $10.8 Million
14,881 Added 5.61%
280,344 $193 Million
Q2 2022

Aug 10, 2022
BUY
$548.35 - $738.84 $8.46 Million - $11.4 Million
15,428 Added 6.17%
265,463 $157 Million
Q1 2022

Apr 27, 2022
BUY
$595.12 - $698.43 $10.8 Million - $12.7 Million
18,161 Added 7.83%
250,035 $175 Million
Q4 2021

Jan 31, 2022
BUY
$543.48 - $670.97 $5.77 Million - $7.12 Million
10,618 Added 4.8%
231,874 $146 Million
Q3 2021

Oct 20, 2021
BUY
$574.03 - $680.96 $23.1 Million - $27.4 Million
40,261 Added 22.24%
221,256 $134 Million
Q2 2021

Jul 20, 2021
BUY
$472.8 - $558.54 $5.51 Million - $6.51 Million
11,658 Added 6.88%
180,995 $101 Million
Q1 2021

Apr 22, 2021
BUY
$446.73 - $548.2 $14.4 Million - $17.7 Million
32,207 Added 23.49%
169,337 $80.1 Million
Q4 2020

Feb 12, 2021
SELL
$478.3 - $607.98 $2.35 Million - $2.99 Million
-4,915 Reduced 3.46%
137,130 $66.3 Million
Q3 2020

Nov 06, 2020
BUY
$544.75 - $658.21 $4.72 Million - $5.7 Million
8,664 Added 6.5%
142,045 $79.5 Million
Q2 2020

Aug 14, 2020
BUY
$493.32 - $643.92 $23.7 Million - $30.9 Million
47,978 Added 56.18%
133,381 $83.2 Million
Q1 2020

May 13, 2020
BUY
$336.18 - $494.43 $373,159 - $548,817
1,110 Added 1.32%
85,403 $41.7 Million
Q4 2019

Feb 12, 2020
SELL
$274.13 - $376.51 $861,316 - $1.18 Million
-3,142 Reduced 3.59%
84,293 $31.7 Million
Q3 2019

Nov 20, 2019
SELL
$273.46 - $318.39 $10.2 Million - $11.8 Million
-37,187 Reduced 29.84%
87,435 $24.3 Million
Q2 2019

Aug 14, 2019
SELL
$299.6 - $414.82 $7.22 Million - $10 Million
-24,106 Reduced 16.21%
124,622 $39 Million
Q1 2019

May 13, 2019
BUY
$372.08 - $439.57 $10.8 Million - $12.8 Million
29,030 Added 24.25%
148,728 $51.6 Million
Q4 2018

Feb 14, 2019
BUY
$335.82 - $403.04 $4.45 Million - $5.34 Million
13,242 Added 12.44%
119,698 $44.7 Million
Q3 2018

Oct 23, 2018
BUY
$351.14 - $408.51 $1.62 Million - $1.88 Million
4,600 Added 4.52%
106,456 $43 Million
Q2 2018

Aug 02, 2018
BUY
$284.6 - $344.99 $731,706 - $886,969
2,571 Added 2.59%
101,856 $35.1 Million
Q1 2018

Apr 10, 2018
SELL
$315.82 - $393.78 $1.05 Million - $1.31 Million
-3,338 Reduced 3.25%
99,285 $34.2 Million
Q4 2017

Jan 22, 2018
SELL
$358.63 - $469.95 $9.65 Million - $12.6 Million
-26,896 Reduced 20.77%
102,623 $38.6 Million
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $55.9 Million - $65.3 Million
129,519
129,519 $57.9 Million

Others Institutions Holding REGN

# of Institutions
1,466
Shares Held
86.4M
Call Options Held
2.42M
Put Options Held
1.64M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $74.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Chevy Chase Trust Holdings, Inc. Portfolio

Follow Chevy Chase Trust Holdings, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chevy Chase Trust Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Chevy Chase Trust Holdings, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email